RecruitingNot Applicable

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

China4,000 participantsStarted 2010-09

Plain-language summary

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Who can participate

Age range5 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pulmonary arterial hypertension;( WHO1) * chronic thromboembolic pulmonary hypertension; * pulmonary arterial hypertension due to other cause; Exclusion Criteria: * massive hemoptysis; * unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders; * recent recurrent syncope; * pulmonary hypertension due to hypoxia; * pulmonary hypertension due to left heart diseases.

What they're measuring

all cause mortality

Timeframe: 5 years

mean pulmonary arterial pressure after treatment

Timeframe: 5 years

achievement of low risk

Timeframe: 5 years

Trial details

NCT IDNCT02061787

SponsorChinese Pulmonary Vascular Disease Research Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-09-08

Contact for this trial

Zhihong Liu, Doctor

8601088396590 zhihongliufuwai@163.com

View on ClinicalTrials.gov More Pulmonary Hypertension trials